Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data
Yingying Zhang, A. H. Bennett, Andrea Manca, Moshe Mittelman et autres
0 citationsMedical Decision Making
Théo de Witte
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
253Publications signalées
17409Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment
Publications récentes
PROGNOSIS - PROGNOSTIC FACTORS OF OUTCOME AND RISK ASSESSMENT
Moshe Mittelman, Dominic Culligan, Adele Taylor, Alexandra Smith et autres
0 citationsLeukemia Research
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry
Bente M. Houtman, Adele Taylor, Corine van Marrewijk, Alexandra Smith et autres
2 citationsHaematologica
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes
David Rombaut, Sarah Sandmann, Tobias Tekath, Simon Crouch et autres
5 citationsHemaSphere
Inflammatory profile of lower risk myelodysplastic syndromes
Joanne Topping, Adele Taylor, Fatima Nadat, Simon Crouch et autres
16 citationsBritish Journal of Haematology
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
Francesco Onida, Nico Gagelmann, Yves Chalandon, Guido Kobbe et autres
28 citationsBlood
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML ‐10 trial
Frédéric Baron, Fabio Efficace, Laura Cannella, Marian Stevens‐Kroef et autres
0 citationsAmerican Journal of Hematology
Oral decitabine plus cedazuridine versus intravenous decitabine
2 citationsThe Lancet Haematology
P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
Aleksandar Savić, Adele Taylor, Jovanka Ilic, Pierre Fenaux et autres
0 citationsHemaSphere
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study
Igor Stojkov, Annette Conrads‐Frank, Ursula Rochau, Marjan Arvandi et autres
11 citationsBlood Advances
CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?
0 citationsThe Lancet Haematology
Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
Fabio Efficace, Karin A. Koinig, Francesco Cottone, David Bowen et autres
7 citationsCancer Medicine
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.